Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Advances in cardiovascular sciences to be discussed at University of Leicester

Advances in Cardiovascular Sciences are to be showcased in two public lectures at the University of Leicester.

27 Nov 2013

EPCs: A promising therapy for type 1 diabetes

Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.

27 Nov 2013

Research: Human neural stem cells could improve blood flow in critical limb ischemia

New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia is a disease that severely obstructs arteries and reduces the blood flow to legs and feet. CLI remains an unmet clinical problem and with an ageing population and the rise in type II diabetes, the incidence of CLI is expected to increase.

27 Nov 2013

Genetic variation linked to increased levels of triglycerides associated with heart disorders

Researchers at Weill Cornell Medical College have found that a genetic variation that is linked to increased levels of triglycerides -- fats in the blood associated with disorders such as heart disease, type 2 diabetes, obesity and stroke -- is far more common than previously believed and disproportionally affects people of African ancestry.

26 Nov 2013

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their healthcare provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels.

26 Nov 2013

BMI or measure of obesity does not play significant role in weight loss operation, says study

A new study investigating why obese patients choose one type of weight loss operation over another reveals that the main factors influencing decision making are whether patients have type 2 diabetes, how much weight they want to lose, and their tolerance for surgical risk to achieve their ideal weight.

25 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.

22 Nov 2013

Targeting single enzyme in the obese could help prevent and treat diabetes

A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.

22 Nov 2013

Type 2 diabetes cytokine elevation places teeth at risk

Scientists have detected significant differences in the cytokine and chemokine make up of gingival crevicular fluid taken from chronic periodontitis patients with uncontrolled Type 2 diabetes and those without.

21 Nov 2013

Unemployed men show signs of faster ageing in their DNA

Men who are unemployed for more than two years show signs of faster ageing in their DNA, a new study has found.

21 Nov 2013

Voxiva launches new mobile app for Care4life Diabetes self-management program

Voxiva, Inc. announces the launch of a new mobile app for its Care4life(SM) Diabetes self-management program. Care4life provides personalized diabetes education and support using highly credible content, evidence-based behavior change methods, and personalized communications to engage and support people with type 2 diabetes.

21 Nov 2013

People who consume nuts daily are 20% less likely to die

In the largest study of its kind, people who ate a daily handful of nuts were 20 percent less likely to die from any cause over a 30-year period than were those who didn't consume nuts, say scientists from Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Harvard School of Public Health.

21 Nov 2013

Chronic diseases account for increasing proportion of GPs' workload

GPs in Australia are working three hours less per week in direct clinical care, however they are dealing with more health problems per visit, research led by the University of Sydney shows.

19 Nov 2013

New $3.4 million NIH grant to fund artificial pancreas projects

A high-tech project to turn an ordinary smart phone into an artificial pancreas that could transform the lives of people with type 1 diabetes has received a $3.4 million grant from the National Institutes of Health.

19 Nov 2013

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Columbia University Medical Center has honored Philipp E. Scherer, PhD, with the 15th Naomi Berrie Award for Outstanding Research in Diabetes, for his work that helped usher in a new understanding of fat and its role in diabetes and other metabolic diseases. His discovery of adiponectin, a hormone produced by fat, helped transform the scientific concept of fat as an inert storage depot to one of it as an endocrine "organ" that exerts control over the brain, muscles, and other organs. The award, given annually by CUMC's Naomi Berrie Diabetes Center, is Columbia's top honor for excellence in diabetes research.

19 Nov 2013

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Advances in cardiovascular sciences to be discussed at University of Leicester

EPCs: A promising therapy for type 1 diabetes

Research: Human neural stem cells could improve blood flow in critical limb ischemia

Genetic variation linked to increased levels of triglycerides associated with heart disorders

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

BMI or measure of obesity does not play significant role in weight loss operation, says study

Researchers discover how type 2 diabetes drug metformin actually works

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

Targeting single enzyme in the obese could help prevent and treat diabetes

Type 2 diabetes cytokine elevation places teeth at risk

Unemployed men show signs of faster ageing in their DNA

Voxiva launches new mobile app for Care4life Diabetes self-management program

People who consume nuts daily are 20% less likely to die

Chronic diseases account for increasing proportion of GPs' workload

New $3.4 million NIH grant to fund artificial pancreas projects

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Researchers update promising strategies and therapies to restore skeletal muscle health

New smartphone app aims to help diabetic young people keep safe when drinking alcohol

Scientists receive $2.2M grant to improve treatments for immune disorders, inflammatory diseases

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in